Articles citing this paper

Associate Professor Jagat R Kanwar is the Head of Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research. His group is currently working on drug discovery and nanomedicine for oral and systemic drug delivery of a range of biomacromolecules (proteins/peptides, siRNAs and aptamers) for targeting cancer, chronic inflammation and neurodegenerative disorders. He is the Editor, Reviewer and Editorial Advisory Board Member of more than 18 international journals. He has been an active member of various professional bodies including American Society of Nanomedicine, Australian Nanotechnology network.

Dr Rupinder K Kanwar is a biomedical researcher with expertise in studying the molecular mechanisms and devising treatments for human chronic inflammatory diseases and cancer. She is key inventor in more than 20 published and live patents/applications and has 60 publications in high ranking journals including 5 book chapters.

Ganesh Mahidhara has received a bachelor’s degree from Osmania University and did masters of Biotechnology from University of Hyderabad in 2006. He is currently pursuing PhD programme in ITRI, Deakin University, after obtaining international postgraduate research scholarship. His area of study is targeting solid tumours by using bio-degradable nano-therapeutics carrying natural anti-cancer proteins.

Dr. Chun Hei Antonio Cheung received his Ph.D. degree from the University of Auckland, New Zealand, and then undertook his post-doctoral study at the National Health Research Institutes in Taiwan. He is currently an assistant professor in pharmacology at the National Cheng Kung University in Taiwan R.O.C.